Gene Therapy Market- Size, Trend Analysis, Industry Share, Current Growth, Top Major Players & Forecast to 2027
In May 2022, Novartis AG (Switzerland) received FDA approval for KYMRIAH for adult patients with relapsed or refractory follicular lymphoma after two or more lines of systemic therapy.
View full press release